Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) provide cardiovascular and kidney benefits in non-KT recipients, but evidence in KT recipients remains limited
Hengrui Pharma chief strategy officer Frank Jiang speaks at Endpoints' #JPM26 event (Brian Benton Photography) Can a Chinese drugmaker become a big pharma company
Drawing on her experience as a talent executive and mentor, she writes about the policies, people and programs shaping the military community.
de L-Carnitina por 1 comprimido, en forma libre para maximizar su absorcin
How does glutathione improve skin tone and reduce pigmentation
Notably, studies in mice demonstrate that GLP-1R agonists specifically localize to and require arginine vasopressin neurons in the PVN to exert their hypophagic and weight-reducing effects, a process that is amplified by GIPR co-activation [81]